Arkansas Legal Resource Navigator

20-13-1303. Definitions.

Arkansas Code — all titles (historical 2020) · legal_authorities

20-13-1303. Definitions.

20-13-1303. Definitions. As used in this subchapter: (1) “Automated external defibrillator” means a device that: (A) Is used to administer an electric shock through the chest wall to the heart; (B) Has built-in computers within the device to assess the patient's heart rhythm, judge whether defibrillation is needed, and then administer the shock; (C) Has audible or visual prompts, or both, to guide the user through the process; (D) Has received approval from the United States Food and Drug Administration of its premarket modification, filed pursuant to 21 U.S.C. § 360(k); (E) Is capable of recognizing the presence or absence of ventricular fibrillation and rapid ventricular tachycardia and is capable of determining without intervention by an operator whether defibrillation should be performed; and (F) Upon determining that defibrillation should be performed, either automatically charges and delivers an electrical impulse to an individual's heart or charges and delivers an electrical impulse at the command of the operator; (2) “Cardiac arrest” means a condition, often sudden, that is due to abnormal heart rhythms called arrhythmias. It is generally the result of some underlying form of heart disease; (3) “Cardiopulmonary resuscitation” means a combination of rescue breathing and chest compressions and external cardiac massage used to sustain a person's life until advanced assistance arrives; (4) “Defibrillation” means administering an electrical impulse to an individual's heart in order to stop ventricular fibrillation or rapid ventricular tachycardia; (5) “Emergency medical services” means the transportation and medical care provided the ill or injured before arrival at a medical facility by a certified emergency medical technician or other healthc

Source: Arkansas Code — historical release 78 (November 6, 2020) · 20-13-1303

Stored review status: Historical 2020-11-06 source release; later amendments not reconciled; machine-extracted, not independently legally reviewed; source heading status: text_in_historical_source. A text match is a research starting point; applicability is not established.

Issuing source page ↗

Authority boundary: historical statutory source snapshot not current law.

Open the recorded source website ↗

Record provenance

Stable record: arkansas_code:legal_authorities:20-13-1303
Source file: gov.ar.code.title.20.odt
Pages: Not recorded – Not recorded
Passage SHA-256: 75dfcad44240331b9d78c8415ae1e6d7980e06f149246cd39b804da74b5344f7

Source location: content.xml paragraph 9669

Stored source content

20-13-1303. Definitions. As used in this subchapter: (1) “Automated external defibrillator” means a device that: (A) Is used to administer an electric shock through the chest wall to the heart; (B) Has built-in computers within the device to assess the patient's heart rhythm, judge whether defibrillation is needed, and then administer the shock; (C) Has audible or visual prompts, or both, to guide the user through the process; (D) Has received approval from the United States Food and Drug Administration of its premarket modification, filed pursuant to 21 U.S.C. § 360(k); (E) Is capable of recognizing the presence or absence of ventricular fibrillation and rapid ventricular tachycardia and is capable of determining without intervention by an operator whether defibrillation should be performed; and (F) Upon determining that defibrillation should be performed, either automatically charges and delivers an electrical impulse to an individual's heart or charges and delivers an electrical impulse at the command of the operator; (2) “Cardiac arrest” means a condition, often sudden, that is due to abnormal heart rhythms called arrhythmias. It is generally the result of some underlying form of heart disease; (3) “Cardiopulmonary resuscitation” means a combination of rescue breathing and chest compressions and external cardiac massage used to sustain a person's life until advanced assistance arrives; (4) “Defibrillation” means administering an electrical impulse to an individual's heart in order to stop ventricular fibrillation or rapid ventricular tachycardia; (5) “Emergency medical services” means the transportation and medical care provided the ill or injured before arrival at a medical facility by a certified emergency medical technician or other healthcare provider and continuation of the initial emergency care within a medical facility subject to the approval of the medical staff and governing board of that facility; (6) “Person” means any individual, partnership, association, corporation, or any organized group of persons whether incorporated or not; and (7) “Ventricular fibrillation” means the most common arrhythmia that causes cardiac arrest. It is a condition in which the heart's electrical impulses suddenly become chaotic, often without warning, causing the heart's pumping action to stop abruptly.

Cross-references

Connections may be documented source relationships, shared citations or nearby passages. Each explains its basis; a connection alone does not establish applicability to your situation.

Federal law — U.S. Code and appendices · legal_authorities

21 U.S.C. § 360 — Registration of producers of drugs or devices

**(a) Definitions** As used in this section— (1) the term “manufacture, preparation, propagation, compounding, or processing” shall include repackaging or otherwise changing the container, wrapper, or labeling of any drug package or device package in furtherance of the distribution of the drug or device from the original place of manufacture to the person who makes final delivery or sale to the ultimate consumer or user; and (2) the term “name” shall include in the case of a partnership the name of each partner and, in the case of a corporation, the name of each corporate officer and director, and the State of incorporation. **(b) Annual registration** (1) During the period beginning on October 1 and ending on December 31 of each year, every person who owns or operates any establishment in any State engaged in the manufacture, preparation, propagation, compounding, or processing of a drug or drugs shall register with the Secretary the name of such person, places of business of such person, all such establishments, the unique facility identifier of each such establishment, and a point of contact e-mail address. (2) During the period beginning on October 1 and ending on December 31 of each year, every person who owns or operates any establishment in any State engaged in the manufacture, preparation, propagation, compounding, or processing of a device or devices shall register with the Secretary his name, places of business, and all such establishments. (3) The Secretary shall specify the unique facility identifier system that shall be used by registrants under paragraph (1). The requirement to include a unique facility identifier in a registration under paragraph (1) shall not apply until the date that the identifier system is specified by the Secretary under the pr

Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 360

Stored review status: release_metadata_unconfirmed. The source passage cites 21 U.S.C. § 360. This identifies an authority to review, not proof of applicability.

Federal law — U.S. Code and appendices · legal_authorities

21 U.S.C. § 360 — Registration of producers of drugs or de-

Page 301 TITLE 21—FOOD AND DRUGS § 360 1 So in original. sections 358 to 360 of this title, amended sections 351 to 353, 355, and 357 of this title, and enacted provisions set out as notes under sections 352, 355, 358, and 360 of this title. The Drug Amendments of 1962, referred to in text, is Pub. L. 87–781, Oct. 10, 1962, 76 Stat. 780, as amended. For complete classification of this Act to the Code, see Short Title of 1962 Amendment note set out under sec- tion 301 of this title and Tables. § 360. Registration of producers of drugs or de- vices (a) Definitions As used in this section— (1) the term ‘‘manufacture, preparation, propagation, compounding, or processing’’ shall include repackaging or otherwise chang- ing the container, wrapper, or labeling of any drug package or device package in furtherance of the distribution of the drug or device from the original place of manufacture to the per- son who makes final delivery or sale to the ul- timate consumer or user; and (2) the term ‘‘name’’ shall include in the case of a partnership the name of each partner and, in the case of a corporation, the name of each corporate officer and director, and the State of incorporation. (b) Annual registration (1) During the period beginning on October 1 and ending on December 31 of each year, every person who owns or operates any establishment in any State engaged in the manufacture, prepa- ration, propagation, compounding, or processing of a drug or drugs shall register with the Sec- retary the name of such person, places of busi- ness of such person, all such establishments, the unique facility identifier of each such establish- ment, and a point of contact e-mail address. (2) During the period beginning on October 1 and ending on December 31 of ea

Source: Supplied 2024 U.S. Code historical extraction · 21 U.S.C. § 360

Stored review status: historical_2024_not_currentness_verified. The source passage cites 21 U.S.C. § 360. This identifies an authority to review, not proof of applicability.